Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 271


Current Challenges and Solutions in Research and Clinical Care of Older Persons Living with HIV: Findings Presented at the 9th International Workshop on HIV and Aging.

Sundermann E, Erlandson KM, Pope CN, Rubtsova A, Montoya JL, Moore A, Marzolini C, O'Brien K, Pahwa S, Payne B, Rubin L, Walmsley S, Haughey N, Montano M, Karris M, Margolick JB, Moore DJ.

AIDS Res Hum Retroviruses. 2019 Aug 2. doi: 10.1089/AID.2019.0100. [Epub ahead of print]


A longitudinal study of associations between HIV-related stigma, recent violence and depression among women living with HIV in a Canadian cohort study.

Logie CH, Marcus N, Wang Y, Kaida A, O'Campo P, Ahmed U, O'Brien N, Nicholson V, Conway T, de Pokomandy A, Fernet M, Loutfy M; CHIWOS Research Team.

J Int AIDS Soc. 2019 Jul;22(7):e25341. doi: 10.1002/jia2.25341.


Hiring, training, and supporting Peer Research Associates: Operationalizing community-based research principles within epidemiological studies by, with, and for women living with HIV.

Kaida A, Carter A, Nicholson V, Lemay J, O'Brien N, Greene S, Tharao W, Proulx-Boucher K, Gormley R, Benoit A, Bernier M, Thomas-Pavanel J, Lewis J, de Pokomandy A, Loutfy M; CHIWOS Research Team.

Harm Reduct J. 2019 Jul 18;16(1):47. doi: 10.1186/s12954-019-0309-3.


Drug interactions are not always predictable: the curious case of valproic acid and dolutegravir and a possible explanation.

Tseng AL, Wong AYJ, McLelland CJ, Walmsley SL.

AIDS. 2019 Aug 1;33(10):1677-1679. doi: 10.1097/QAD.0000000000002256. No abstract available.


Heart Failure With Preserved Ejection Fraction in Women Living With HIV: Another Inflammatory Comorbidity?

Moayedi Y, Walmsley SL.

J Infect Dis. 2019 Apr 22. pii: jiz185. doi: 10.1093/infdis/jiz185. [Epub ahead of print] No abstract available.


Lymphocytic colitis in an HIV positive patient: is dolutegravir the cause?

Mclelland CJ, Tseng AL, Walmsley SL, Chakrabarti S.

AIDS. 2019 Jun 1;33(7):1265-1266. doi: 10.1097/QAD.0000000000002203. No abstract available.


Trends in cause-specific mortality in HIV-hepatitis C coinfection following hepatitis C treatment scale-up.

Kronfli N, Bhatnagar SR, Hull MW, Moodie EEM, Cox J, Walmsley S, Gill J, Cooper C, Martel-Laferrière V, Pick N, Klein MB; Canadian Co-Infection Cohort Investigators.

AIDS. 2019 May 1;33(6):1013-1022. doi: 10.1097/QAD.0000000000002156.


Love with HIV: A Latent Class Analysis of Sexual and Intimate Relationship Experiences Among Women Living with HIV in Canada.

Carter A, Greene S, Money D, Sanchez M, Webster K, Nicholson V, Brotto LA, Hankins C, Kestler M, Pick N, Salters K, Proulx-Boucher K, O'Brien N, Patterson S, de Pokomandy A, Loutfy M, Kaida A; CHIWOS Research Team.

Arch Sex Behav. 2019 May;48(4):1015-1040. doi: 10.1007/s10508-019-1418-5. Epub 2019 Mar 19.


Direct-Acting Antiviral Treatment Failure Among Hepatitis C and HIV-Coinfected Patients in Clinical Care.

Rossi C, Young J, Martel-Laferrière V, Walmsley S, Cooper C, Wong A, Gill MJ, Klein MB; Canadian Co-Infection Cohort Investigators .

Open Forum Infect Dis. 2019 Feb 13;6(3):ofz055. doi: 10.1093/ofid/ofz055. eCollection 2019 Mar.


Tenofovir and emtricitabine resistance among antiretroviral-naive patients in the Canadian Observational Cohort Collaboration: implications for PrEP.

Younger J, Raboud J, Szadkowski L, Harrigan R, Walmsley S, Bayoumi AM, Klein MB, Cooper C, Burchell AN, Loutfy M, Hull M, Wong A, Thomas R, Hogg R, Montaner J, Tsoukas C, Antoniou T; Canadian Observational Cohort Collaboration.

Antivir Ther. 2019 Mar 15. doi: 10.3851/IMP3302. [Epub ahead of print]


A Latent Class Analysis of the Social Determinants of Health Impacting Heavy Alcohol Consumption Among Women Living with HIV in Canada: The Canadian HIV Women's Sexual and Reproductive Health Cohort Study.

Shokoohi M, Bauer GR, Kaida A, Logie CH, Carter A, Lacombe-Duncan A, Loutfy M; CHIWOS Research Team.

AIDS Behav. 2019 Mar 12. doi: 10.1007/s10461-019-02454-3. [Epub ahead of print]


Trends in cause-specific mortality in HIV-Hepatitis C co-infection following hepatitis C treatment scale-up.

Kronfli N, Bhatnagar SR, Hull MW, Moodie EEM, Cox J, Walmsley S, Gill J, Cooper C, Martel-Laferriere V, Pick N, Klein MB; Canadian Co-Infection Cohort Investigators.

AIDS. 2019 Jan 12. doi: 10.1097/QAD.0000000000002156. [Epub ahead of print]


Variation in hepatitis C virus treatment uptake between Canadian centres in the era of direct-acting antivirals.

Nitulescu R, Young J, Saeed S, Cooper C, Cox J, Martel-Laferriere V, Hull M, Walmsley S, Tyndall M, Wong A, Klein MB; Canadian Co-Infection Cohort Study.

Int J Drug Policy. 2019 Mar;65:41-49. doi: 10.1016/j.drugpo.2018.08.012. Epub 2018 Dec 26.


Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV-HCV co-infected patients in Canada.

Kronfli N, Nitulescu R, Cox J, Moodie EE, Wong A, Cooper C, Gill J, Walmsley S, Martel-Laferrière V, Hull MW, Klein MB; Canadian Co-Infection Cohort Study.

J Int AIDS Soc. 2018 Nov;21(11):e25197. doi: 10.1002/jia2.25197.


Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials.

Cahn P, Madero JS, Arribas JR, Antinori A, Ortiz R, Clarke AE, Hung CC, Rockstroh JK, Girard PM, Sievers J, Man C, Currie A, Underwood M, Tenorio AR, Pappa K, Wynne B, Fettiplace A, Gartland M, Aboud M, Smith K; GEMINI Study Team.

Lancet. 2019 Jan 12;393(10167):143-155. doi: 10.1016/S0140-6736(18)32462-0. Epub 2018 Nov 9. Erratum in: Lancet. 2018 Nov 28;:.


Successful use of the potent enzyme inducer enzalutamide in a treatment-experienced HIV-positive male with prostate cancer.

Nhean S, Bravo J, Sheehan NL, Walmsley S, Tilley D, Tseng AL.

AIDS. 2018 Nov 13;32(17):2640-2642. doi: 10.1097/QAD.0000000000002019. No abstract available.


Effect of valaciclovir on CD4 count decline in untreated HIV: an international randomized controlled trial.

Tan DHS, Raboud JM, Szadkowski L, Grinsztejn B, Madruga JV, Figueroa MI, Cahn P, Barton SE, Clarke A, Fox J, Zubyk W, Walmsley SL; VALIDATE Study Group .

J Antimicrob Chemother. 2019 Feb 1;74(2):480-488. doi: 10.1093/jac/dky433.


Real-world impact of direct acting antiviral therapy on health-related quality of life in HIV/Hepatitis C co-infected individuals.

Saeed S, Moodie EEM, Strumpf E, Gill J, Wong A, Cooper C, Walmsley S, Hull M, Martel-Laferriere V, Klein MB; Canadian Co-Infection Cohort Study Investigators.

J Viral Hepat. 2018 Dec;25(12):1507-1514. doi: 10.1111/jvh.12985. Epub 2018 Sep 27.


Emergence of Carbapenemase-Producing Enterobacteriaceae, South-Central Ontario, Canada1.

Kohler PP, Melano RG, Patel SN, Shafinaz S, Faheem A, Coleman BL, Green K, Armstrong I, Almohri H, Borgia S, Borgundvaag E, Johnstone J, Katz K, Lam F, Muller MP, Powis J, Poutanen SM, Richardson D, Rebbapragada A, Sarabia A, Simor A, McGeer A; Toronto Invasive Bacterial Diseases Network (TIBDN).

Emerg Infect Dis. 2018 Sep;24(9):1674-1682. doi: 10.3201/eid2409.180164.


The Efficacy of the Quadrivalent Human Papillomavirus Vaccine in Girls and Women Living With Human Immunodeficiency Virus.

McClymont E, Lee M, Raboud J, Coutlée F, Walmsley S, Lipsky N, Loutfy M, Trottier S, Smaill F, Klein MB, Harris M, Cohen J, Yudin MH, Wobeser W, Money D; CTN 236 HPV in HIV Study Team .

Clin Infect Dis. 2019 Feb 15;68(5):788-794. doi: 10.1093/cid/ciy575.


Supplemental Content

Loading ...
Support Center